Corcept Therapeutics (CORT)
NASDAQ: CORT
· Real-Time Price · USD
82.73
-1.11 (-1.32%)
At close: Sep 25, 2025, 3:59 PM
83.87
1.38%
After-hours: Sep 25, 2025, 05:14 PM EDT
-1.32% (1D)
| Bid | 81 |
| Market Cap | 8.72B |
| Revenue (ttm) | 716.08M |
| Net Income (ttm) | 132.52M |
| EPS (ttm) | 1.12 |
| PE Ratio (ttm) | 73.87 |
| Forward PE | 38.05 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 84 |
| Volume | 658,380 |
| Avg. Volume (20D) | 1,166,456 |
| Open | 83.38 |
| Previous Close | 83.84 |
| Day's Range | 81.99 - 84.24 |
| 52-Week Range | 42.01 - 117.33 |
| Beta | 0.29 |
| Ex-Dividend Date | n/a |
About CORT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CORT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CORT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsCorcept Therapeutics is scheduled to release its earnings on
Oct 29, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
-7.58%
Corcept Therapeutics shares are trading lower. The...
Unlock content with
Pro Subscription
4 months ago
-4.33%
Corcept Therapeutics shares are trading lower after the company reported worse-than-expected Q1 sales results. Also, HC Wainwright maintained a Buy rating on the stock but lowered its price target from $150 to $145.
1 month ago · seekingalpha.com
Corcept Therapeutics Incorporated (CORT) Q2 2025 Earnings Call TranscriptCorcept Therapeutics Incorporated (NASDAQ:CORT ) Q2 2025 Earnings Call July 31, 2025 5:00 PM ET Company Participants Atabak Mokari - CFO & Treasurer Gary Charles Robb - Chief Business Officer & Secret...
